Mrs Julia Rose Davison, PHARM D RPH | |
692 E Street, Williams, CA 95987-0039 | |
(530) 473-5350 | |
(530) 473-5613 |
Full Name | Mrs Julia Rose Davison |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 692 E Street, Williams, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265508915 | NPI | - | NPPES |
42599 | Other | CA | BOARD OF PHARMACY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 42599 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Julia Rose Davison, PHARM D RPH 692 E Street, Williams, CA 95987-0039 Ph: (530) 473-5350 | Mrs Julia Rose Davison, PHARM D RPH 692 E Street, Williams, CA 95987-0039 Ph: (530) 473-5350 |
News Archive
'Grid cells' that act like a spatial map in the brain have been identified for the first time in humans, according to new research by UCL scientists which may help to explain how we create internal maps of new environments.
Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer.
Young people's satisfaction with their family situation is clearly related to the quality of relationships with parents and especially their mother's happiness. The research findings come from the first findings from Understanding Society, the world's largest household panel study managed by the Institute for Social and Economic Research at the University of Essex.
State representatives and senators got a call for more research funding to prevent pregnancy complications from a Yale School of Medicine researcher at the 7th annual Women In Government regional conference on September 28.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
› Verified 7 days ago